7 completed. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow BiondVax Pharmaceuticals ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine M-001, Saline - Influenza | Phase 3 | Completed | BiondVax Pharmaceuticals ltd. | 12460 | 2018-08-01 | 2021-10-05 |
| Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults Multimeric 001 (M-001), H5N1 influenza vaccine, Saline - Influenza, Healthy | Phase 2 | Completed | BiondVax Pharmaceuticals ltd. | 224 | 2015-11-01 | 2018-02-09 |
| Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV M-001, TIV, Saline - Influenza | Phase 2 | Completed | BiondVax Pharmaceuticals ltd. | 37 | 2014-11-01 | 2016-02-23 |
| A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers Two Multimeric-001 administrations followed by TIV, One administration of Multimeric-001 followed by TIV, One administration of adjuvanted M-001 followed by TIV - Influenza, Healthy | Phase 2 | Completed | BiondVax Pharmaceuticals ltd. | 120 | 2011-08-01 | 2014-05-13 |
| Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001) Multimeric-001, 500 mcg, Adjuvanted PBS, PBS and TIV 15% - Influenza | Phase 2 | Completed | BiondVax Pharmaceuticals ltd. | 200 | 2010-07-01 | 2012-07-31 |
| A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers Multimeric-001 250 mcg, Adjuvanted Multimeric-001 250mcg, Placebo - Influenza | Phase 1 / Phase 2 | Completed | BiondVax Pharmaceuticals ltd. | 60 | 2009-09-01 | 2012-07-31 |
| A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Adjuvanted Multimeric-001 250 Mcg, Multimeric-001 250 Mcg, Phosphate Buffered saline - Healthy | Phase 1 / Phase 2 | Completed | BiondVax Pharmaceuticals ltd. | 63 | 2009-06-01 | 2023-03-07 |
Influenza, Human (7) · HIV Seropositivity (1)
Sodium Chloride (3) · PN M001 (2) · vaxigrip (1)
Israel (5) · Hungary (1) · Poland (1)
Jacob Atsmon, MD (3) · Dora Mathiasz, MD (1) · Dr. Jacob Atzmon, MD (1) · Tamar Ben Yedidia, PhD (1) · Tamar Ben-Yedidia, PhD (1) · Yosef Caraco, Phd (1)